Koru Medical Systems Inc (KRMD)

$5.68 -0.04 (-0.70%)
Market Cap 264.97M
Revenue (ttm) 33.65M
Net Income (ttm) -6.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.04%
Debt to Equity Ratio 0.00
Volume 178,200
Avg Vol 126,426
Day's Range N/A - N/A
Shares Out 46.32M
Stochastic %K 78%
Beta 0.58
Analysts Strong Sell
Price Target $5.65

Company Profile

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobin...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 845-469-2042
Fax: 845 469 5518
Address:
100 Corporate Drive, Mahwah, United States
theDIOyears
theDIOyears Dec. 1 at 3:40 AM
$XTNT Yall see that they updated the Xtant Medical website? Under 0.60, bottom BOLL line. Ive been buying have you? Someone tell Trader to buy low, sell high for me. $XBI $KRMD
1 · Reply
_www_larval_com_
_www_larval_com_ Nov. 26 at 8:52 PM
$SPRC -3%[-11%] $KRMD -3%[8%] most notable movement into the final minutes of trading.
0 · Reply
Gesundheit
Gesundheit Nov. 21 at 8:57 PM
$KRMD I knew you could do it Linda Tharby! Been here quietly since 2021. I have no idea why KRMD has not garnered any attention. Up from 1.50 is not too bad.
0 · Reply
prismmarketview
prismmarketview Nov. 18 at 3:51 PM
(NASDAQ: $KRMD) KORU Medical will present new data at ESID/EHA/SIOPE 2025 showing strong nurse and patient preference for its FreedomEDGE® subcutaneous infusion system. In a nine-hospital study, 91% of nurses reported easier, faster use, and 97% of respondents would recommend it—supporting its role in easing infusion-center workloads. https://prismmarketview.com/koru-medical-to-showcase-new-data-on-freedomedge-infusion-system-at-esid-eha-siope-2025-symposium/
0 · Reply
AdLucrum
AdLucrum Nov. 15 at 7:33 PM
$KRMD A close above $4.40 and I'm in. This looks good.
1 · Reply
IPO_Candy
IPO_Candy Nov. 13 at 2:25 PM
Some very good reports $IDN $CURI are top names. Still good were $IZEA and $KRMD . It's another rambling story with $PLBY who needs a new CEO.
0 · Reply
DARKP00L
DARKP00L Nov. 12 at 9:21 PM
$KRMD 16:07 on Nov. 12 2025 KORU Medical Systems Raises FY2025 Sales Guidance from $39.500M-$40.500M to $40.500M-$41.000M vs $39.940M Est #tradeideas
0 · Reply
DARKP00L
DARKP00L Nov. 12 at 9:21 PM
$KRMD 16:06 on Nov. 12 2025 KORU Medical Systems Q3 Sales $10.402M Beat $9.666M Estimate #tradeideas
0 · Reply
Gesundheit
Gesundheit Nov. 12 at 9:20 PM
$KRMD https://investors.korumedical.com/news-events/press-releases/detail/186/koru-medical-systems-announces-27-q3-revenue-growth-and-raises-2025-revenue-guidance
0 · Reply
GoGreen21
GoGreen21 Oct. 27 at 11:32 AM
$KRMD Been waiting for this day for 4 years.
1 · Reply
Latest News on KRMD
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

Nov 17, 2025, 4:05 PM EST - 17 days ago

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

KORU Medical Systems to Participate in Upcoming Investor Conferences

Nov 13, 2025, 8:00 AM EST - 22 days ago

KORU Medical Systems to Participate in Upcoming Investor Conferences

KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 8:41 PM EST - 22 days ago

KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

Nov 12, 2025, 4:05 PM EST - 22 days ago

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

Nov 4, 2025, 4:05 PM EST - 4 weeks ago

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 22, 2025, 4:05 PM EDT - 6 weeks ago

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Sep 18, 2025, 8:00 AM EDT - 2 months ago

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Cirtec Medical Announces Appointment of New Chief Executive Officer

Aug 28, 2025, 12:59 PM EDT - 3 months ago

Cirtec Medical Announces Appointment of New Chief Executive Officer

KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:23 AM EDT - 4 months ago

KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

Aug 6, 2025, 4:05 PM EDT - 4 months ago

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 1, 2025, 4:55 PM EDT - 4 months ago

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 30, 2025, 4:05 PM EDT - 4 months ago

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 16, 2025, 4:05 PM EDT - 5 months ago

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

Jul 7, 2025, 4:05 PM EDT - 5 months ago

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

Jun 11, 2025, 4:05 PM EDT - 6 months ago

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript

May 11, 2025, 8:12 AM EDT - 7 months ago

KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

May 7, 2025, 4:05 PM EDT - 7 months ago

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 10:34 PM EDT - 9 months ago

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

Mar 12, 2025, 4:05 PM EDT - 9 months ago

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Feb 19, 2025, 4:05 PM EST - 10 months ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

KORU Medical Systems Has A Long Runway

Feb 10, 2025, 12:11 AM EST - 10 months ago

KORU Medical Systems Has A Long Runway

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Feb 6, 2025, 4:05 PM EST - 10 months ago

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Jan 30, 2025, 4:05 PM EST - 11 months ago

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

Jan 13, 2025, 8:00 AM EST - 11 months ago

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 25, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:57 PM EST - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Nov 13, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Impressive Turnaround At KORU Medical

Nov 6, 2024, 8:34 AM EST - 1 year ago

Impressive Turnaround At KORU Medical

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

Oct 31, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

Oct 23, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Sep 5, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:52 PM EDT - 1 year ago

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

Aug 7, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jul 25, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

Jul 24, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 17, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Jul 2, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Jun 5, 2024, 9:00 AM EDT - 1 year ago

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

Jun 4, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

May 14, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

May 1, 2024, 10:11 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

May 1, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 17, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Apr 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

Mar 18, 2024, 5:24 PM EDT - 1 year ago

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 8:27 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

Mar 13, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

Mar 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

Mar 6, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Feb 21, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

theDIOyears
theDIOyears Dec. 1 at 3:40 AM
$XTNT Yall see that they updated the Xtant Medical website? Under 0.60, bottom BOLL line. Ive been buying have you? Someone tell Trader to buy low, sell high for me. $XBI $KRMD
1 · Reply
_www_larval_com_
_www_larval_com_ Nov. 26 at 8:52 PM
$SPRC -3%[-11%] $KRMD -3%[8%] most notable movement into the final minutes of trading.
0 · Reply
Gesundheit
Gesundheit Nov. 21 at 8:57 PM
$KRMD I knew you could do it Linda Tharby! Been here quietly since 2021. I have no idea why KRMD has not garnered any attention. Up from 1.50 is not too bad.
0 · Reply
prismmarketview
prismmarketview Nov. 18 at 3:51 PM
(NASDAQ: $KRMD) KORU Medical will present new data at ESID/EHA/SIOPE 2025 showing strong nurse and patient preference for its FreedomEDGE® subcutaneous infusion system. In a nine-hospital study, 91% of nurses reported easier, faster use, and 97% of respondents would recommend it—supporting its role in easing infusion-center workloads. https://prismmarketview.com/koru-medical-to-showcase-new-data-on-freedomedge-infusion-system-at-esid-eha-siope-2025-symposium/
0 · Reply
AdLucrum
AdLucrum Nov. 15 at 7:33 PM
$KRMD A close above $4.40 and I'm in. This looks good.
1 · Reply
IPO_Candy
IPO_Candy Nov. 13 at 2:25 PM
Some very good reports $IDN $CURI are top names. Still good were $IZEA and $KRMD . It's another rambling story with $PLBY who needs a new CEO.
0 · Reply
DARKP00L
DARKP00L Nov. 12 at 9:21 PM
$KRMD 16:07 on Nov. 12 2025 KORU Medical Systems Raises FY2025 Sales Guidance from $39.500M-$40.500M to $40.500M-$41.000M vs $39.940M Est #tradeideas
0 · Reply
DARKP00L
DARKP00L Nov. 12 at 9:21 PM
$KRMD 16:06 on Nov. 12 2025 KORU Medical Systems Q3 Sales $10.402M Beat $9.666M Estimate #tradeideas
0 · Reply
Gesundheit
Gesundheit Nov. 12 at 9:20 PM
$KRMD https://investors.korumedical.com/news-events/press-releases/detail/186/koru-medical-systems-announces-27-q3-revenue-growth-and-raises-2025-revenue-guidance
0 · Reply
GoGreen21
GoGreen21 Oct. 27 at 11:32 AM
$KRMD Been waiting for this day for 4 years.
1 · Reply
Doozio
Doozio Oct. 23 at 1:20 PM
$KRMD it was always chop chop huckleberries 🐒🍌🧠⏰♾️
0 · Reply
StockChartsStudyholic
StockChartsStudyholic Oct. 14 at 9:37 PM
$KRMD 👀
0 · Reply
IPO_Candy
IPO_Candy Oct. 10 at 8:36 PM
$KRMD Oh a green one!
0 · Reply
TradeNiko
TradeNiko Oct. 5 at 9:27 AM
$KRMD Medical device innovation. Testing resistance at descending trendline. Volume pattern constructive for breakout.
0 · Reply
Gesundheit
Gesundheit Sep. 16 at 2:21 PM
$KRMD Looks like we might hit another buy point. It is always sneaky and you have to be ready to hit or set a buy order.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 6:18 AM
$KRMD Excellent article that nails exactly where KRMD stands right now. So if you want to update your KRMD knowledge or get acquainted with KRMD, this is a must read. https://beyondspx.com/quote/KRMD/analysis/koru-medical-systems-nasdaq-krmd-unlocking-growth-through-subcutaneous-innovation-and-global-expansion
0 · Reply
IPO_Candy
IPO_Candy Aug. 25 at 3:49 PM
$KRMD Added this one to the long term portfolio a few months ago. A keeper.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 7 at 6:15 PM
$KRMD KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
0 · Reply
Gesundheit
Gesundheit Aug. 7 at 2:01 AM
$KRMD Nice earnings... https://seekingalpha.com/news/4480681-koru-medical-systems-gaap-eps-of-000-beats-by-003-revenue-of-102m-beats-by-074m
0 · Reply
Gesundheit
Gesundheit Jul. 15 at 8:04 PM
$KRMD This is where you really make serious money. Up and down is usually by about 1.00. Short can now safely be covered at around 2.60 then we will be good for another round. Almost as predictable as your money Market CD.
1 · Reply
Gesundheit
Gesundheit Jul. 7 at 8:11 PM
$KRMD https://investors.korumedical.com/news-events/press-releases/detail/178/koru-medical-systems-appoints-adam-kalbermatten-as-chief-commercial-officer
0 · Reply
davemn
davemn Jun. 28 at 2:51 AM
$KRMD 5.1M! shares today including after hours for the Russell addition. Should be a big back half of the year for Koru with all the 510k’s. Just getting started.
0 · Reply